First Sub-unit Tuberculosis Vaccine Shows Promise to Protect

The results from an innovative clinical trial provide new evidence that Tuberculosis (TB) vaccines could prevent sustained infections in high-risk adolescents. The trial has been conducted by Aeras, a nonprofit organization dedicated to developing vaccines against tuberculosis.

First Subunit Tuberculosis Vaccine Shows Potential to Protect

Tuberculosis vaccine trial results offer potential for BCG Revaccination and subunit vaccines. It is the first ''prevention of infection'' trial conducted for TB. Read More

Related Links

Wildcard SSL

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer

First Sub-unit Tuberculosis Vaccine Shows Promise to Protect

First Subunit Tuberculosis Vaccine Shows Potential to Protect

Related Links

Tuberculosis

Extra Pulmonary Tuberculosis

Opportunistic Infections

Diet in Tuberculosis

Follow Us On :